Skip to content
WeighLab
Menu
Ranked #78 · Grade C

GoodRx review

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Visit GoodRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$299/mo (brand Zepbound)
Coverage
All 50 states
Brand-name
Yes

Tirzepatide · modeled / year

$3,588

The Index scorecard

GoodRx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month81/100
Price Transparency62/100
Nationwide Access86/100
Formulation Options71/100
Clinical Oversight68/100
Contract Flexibility55/100

Where the value is

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

The tradeoffs

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

The bottom line

Best for: Cost-first shoppers who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

Ranked #78 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to GoodRx.

The 24 programs nearest this one

Pricing, states and verification reflect GoodRx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on GoodRx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard